If you are planning to start tirzepatide by a specific date, account for potential delays and order with buffer time
The majority of weight loss drug lawsuits filed claim that the companies failed to warn patients about the risk of delayed gastric emptying, severe gastroparesis, intestinal blockages, and vision loss, such as non-arteritic anterior ischemic optic neuropathy (NAION)
Trulicity Lilly Launches Trulicity in the US First Ever Ready-to-Use Once-Weekly GLP-1 Receptor Agonist Eli Lilly launches Trulicity in the US first ready-to-use once-weekly GLP-1, available with a savings program for commercially insured patients
The protective effect of GLP-1 medications was consistent across racial groups, including Black and white females, and was independent of diabetes status, age, BMI, and breast density
ARTN 1589
Orthodontic products startup KLOwen has recently acquired $10.5 million in investor funding for its custom braces system